PA
CCEP icon

PharVision Advisers’s Coca-Cola Europacific Partners CCEP Stock Holding History

PharVision Advisers’s Portfolio CCEP Stock Details CCEP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,824
Closed -$256K – 189
2025
Q4 		$256K Buy
+2,824
New +$255K 0.13% 380

Other funds holding CCEP

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PharVision Advisers's CCEP Position: Q1 2026 in Review

PharVision Advisers sold out of Coca-Cola Europacific Partners (CCEP) in Q1 2026, closing a stake of 2,824 shares — an estimated $256K sold.

PharVision Advisers first reported a position in CCEP in Q4 2025 and held it in 1 quarter. The position peaked at $256K in Q4 2025. 579 funds tracked by Wall St. Rank hold CCEP as of Q1 2026.

  • PharVision Advisers reported no remaining Coca-Cola Europacific Partners position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 2,824 Coca-Cola Europacific Partners shares in Q1 2026, an estimated $256K.
  • PharVision Advisers first reported a position in Coca-Cola Europacific Partners in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Coca-Cola Europacific Partners position peaked at $256K in Q4 2025.
  • 579 funds tracked by Wall St. Rank held Coca-Cola Europacific Partners as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.